News From Our Illinois Injury and Mass Tort Lawyer Blog
April 2023 News & Updates
MOLL Law Group
The medication Tepezza, prescribed as a treatment for thyroid eye disease or Graves' eye disease, has been linked to permanent hearing loss. 65% of Tepezza patients reported hearing problems to the Endocrine Society.

One man who received Tepezza infusions for his thyroid eye disease from June – September 2020 and was diagnosed with permanent hearing loss has sued Horizon Pharmaceuticals, the manufacturer of Tepezza.
According to the consumer agency, the recall has been issued because there is a faulty wire connection inside the air fryers. This results in air fryers smoking, melting, burning, and otherwise overheating. Several reports made to the CPSC involved burns and other minor injuries; there was also property damage reported. Read More.

Recently, a food additives expert, Professor Erik Millstone, of the England’s University of Sussex, stated that certain additives banned in Europe, along with China and India, have not been banned in the United States. He also noted that most Americans were totally unsuspecting that they were regularly taking in substances that were regarded as dangerous in Europe and other countries. 

Hair relaxer lawsuits filed across the nation alleging ovarian, uterine, and endometrial cancer are consolidated in Illinois. Moll Law Group is representing numerous women claiming their injuries and cancer were caused by hair relaxer use. If you or a loved one suffered injuries or were diagnosed with cancer following hair relaxer use and want to file a claim, please contact us at 312.462.1700 or complete or form at molllawgroup.com.


DEADLINE - Revlon Hair Relaxer users only have until April 11, 2023 to file a claim.

Several companies have faced lawsuits related to injuries caused by their hair relaxers. Recently, the bankruptcy judge responsible for overseeing their Chapter 11 bankruptcy extended the deadline by which consumers with certain types of cancer can file claims against the company. 

A new report shows RECALLS are NOT EFFECTIVE in warning consumers of defective products and removing defective products from the market which continue to cause injuries.
Several brands of over-the-counter eyedrops, including EzriCare Artificial Tears, have been recently recalled due to risks of infection, hospitalization, blindness, and death.